These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25858021)

  • 41. Single agent vinorelbine in pediatric patients with progressive optic pathway glioma.
    Cappellano AM; Petrilli AS; da Silva NS; Silva FA; Paiva PM; Cavalheiro S; Bouffet E
    J Neurooncol; 2015 Jan; 121(2):405-12. PubMed ID: 25366366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Optic pathway gliomas--current position and future directions].
    Shofty B; Constantini S; Freedman S; Ben-Sira L; Kesler A
    Harefuah; 2010 Nov; 149(11):721-5, 748. PubMed ID: 21250414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of bevacizumab in treatment of children with optic pathway glioma].
    Wu WS; Liu JJ; Sun YL; DU SX; Li CD; Li M; Ren SQ; Zhang J; Gong XJ; Sun LM
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Dec; 21(12):1193-1197. PubMed ID: 31874658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence.
    Moreno L; Bautista F; Ashley S; Duncan C; Zacharoulis S
    Eur J Cancer; 2010 Aug; 46(12):2253-9. PubMed ID: 20400294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroophthalmological management of optic pathway gliomas.
    Lee AG
    Neurosurg Focus; 2007; 23(5):E1. PubMed ID: 18004957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
    Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
    Scheinemann K; Bartels U; Tsangaris E; Hawkins C; Huang A; Dirks P; Fried I; Bouffet E; Tabori U
    Pediatr Blood Cancer; 2011 Jul; 57(1):84-8. PubMed ID: 21557457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optic glioma in children: a retrospective analysis of 101 cases.
    Varan A; Batu A; Cila A; Soylemezoğlu F; Balcı S; Akalan N; Zorlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    Am J Clin Oncol; 2013 Jun; 36(3):287-92. PubMed ID: 22547006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visual pathway glioma in children treated with chemotherapy.
    Demaerel P; de Ruyter N; Casteels I; Renard M; Uyttebroeck A; van Gool S
    Eur J Paediatr Neurol; 2002; 6(4):207-12. PubMed ID: 12374587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
    Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
    J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy.
    Lacaze E; Kieffer V; Streri A; Lorenzi C; Gentaz E; Habrand JL; Dellatolas G; Kalifa C; Grill J
    Br J Cancer; 2003 Dec; 89(11):2038-44. PubMed ID: 14647135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy.
    Petronio J; Edwards MS; Prados M; Freyberger S; Rabbitt J; Silver P; Levin VA
    J Neurosurg; 1991 May; 74(5):701-8. PubMed ID: 1901597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of optic pathway hypothalamic gliomas in childhood: experience with 18 consecutive cases.
    Jaing TH; Lin KL; Tsay PK; Hsueh C; Hung PC; Wu CT; Tseng CK
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):222-4. PubMed ID: 18376285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary results of primary chemotherapy in retinoblastoma.
    Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
    Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
    Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
    Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.
    Ronghe M; Hargrave D; Bartels U; Tabori U; Vaidya S; Chandler C; Kulkarni A; Bouffet E
    Pediatr Blood Cancer; 2010 Sep; 55(3):471-7. PubMed ID: 20535831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optic Pathway Gliomas: Clinical Manifestation, Treatment, and Follow-Up.
    Ertiaei A; Hanaei S; Habibi Z; Moradi E; Nejat F
    Pediatr Neurosurg; 2016; 51(5):223-8. PubMed ID: 27082859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; García-Segura JM; Botella MP
    Rev Neurol; 2008 May 1-15; 46(9):530-6. PubMed ID: 18446694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.